Share on StockTwits
 

PAREXEL International Corp. (NASDAQ:PRXL) Director Christopher J. Lindop unloaded 10,000 shares of PAREXEL International Corp. stock on the open market in a transaction dated Tuesday, February 4th. The stock was sold at an average price of $49.00, for a total value of $490,000.00. Following the sale, the director now directly owns 29,593 shares of the company’s stock, valued at approximately $1,450,057. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

PRXL has been the subject of a number of recent research reports. Analysts at Barclays raised their price target on shares of PAREXEL International Corp. from $48.00 to $52.00 in a research note to investors on Thursday, January 30th. They now have an “overweight” rating on the stock. Separately, analysts at ISI Group upgraded shares of PAREXEL International Corp. from a “buy” rating to a “strong-buy” rating in a research note to investors on Wednesday, January 22nd. They now have a $56.00 price target on the stock, up previously from $53.00. Finally, analysts at Thomson Reuters/Verus downgraded shares of PAREXEL International Corp. from a “buy” rating to a “hold” rating in a research note to investors on Monday, January 20th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating, five have issued a buy rating and two have given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $51.56.

Shares of PAREXEL International Corp. (NASDAQ:PRXL) traded down 0.50% during mid-day trading on Thursday, hitting $49.53. The stock had a trading volume of 526,312 shares. PAREXEL International Corp. has a 52 week low of $33.17 and a 52 week high of $55.02. The stock has a 50-day moving average of $46.42 and a 200-day moving average of $47.21. The company has a market cap of $2.799 billion and a price-to-earnings ratio of 25.31.

PAREXEL International Corp. (NASDAQ:PRXL) last posted its quarterly earnings results on Thursday, January 30th. The company reported $0.49 earnings per share for the quarter, meeting the analysts’ consensus estimate of $0.49. The company had revenue of $487.10 million for the quarter, compared to the consensus estimate of $479.49 million. During the same quarter last year, the company posted $0.41 earnings per share. PAREXEL International Corp.’s revenue was up 15.4% compared to the same quarter last year. On average, analysts predict that PAREXEL International Corp. will post $2.05 earnings per share for the current fiscal year.

PAREXEL International Corporation (NASDAQ:PRXL) is a biopharmaceutical services company, providing a range of expertise in clinical research, medical communications, consulting, and advanced technology products and services to the worldwide pharmaceutical, biotechnology, and medical device industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.